Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01540175 | Immune Reconstitution in Oncology Patients Following Autologous Stem Cell Transplant(IROPAST) | completed | — | 31 | St. Jude Children's Research HospitalOTHER | 1 | Jul 14, 2015 | clinicaltrials |
| NCT02496949 | A Phase Ib Study to Assess Safety and Efficacy of Oral Icaritin in Advanced Solid Tumors | completed | Phase 1 | 28 | Chinese Academy of Medical SciencesOTHER | 1 | Jul 14, 2015 |
| clinicaltrials |
| NCT00413075 | Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 121 | Valerio TherapeuticsINDUSTRY | 3 | Jul 8, 2015 | clinicaltrials |
| NCT00608361 | Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery | completed | Phase 1 | 80 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2015 | clinicaltrials |
| NCT01154426 | ABT-888 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 31 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2015 | clinicaltrials |
| NCT01725191 | Tivantinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors | completed | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 2 | Jul 2, 2015 | clinicaltrials |
| NCT01931761 | Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C] Selumetinib in Volunteers | completed | Phase 1 | 6 | AstraZenecaINDUSTRY | 1 | Jun 30, 2015 | clinicaltrials |
| NCT02063204 | To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Renal Impaired Subjects and Healthy Subjects | completed | Phase 1 | 24 | AstraZenecaINDUSTRY | 1 | Jun 30, 2015 | clinicaltrials |
| NCT02093728 | To Assess the Effect of Itraconazole and Fluconazole on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers | completed | Phase 1 | 26 | AstraZenecaINDUSTRY | 1 | Jun 30, 2015 | clinicaltrials |
| NCT00947739 | Phase I and Pharmacology Study of Camptothecin-20-O-Propionate Hydrate (CZ48) in Patients With Solid Tumors or Lymphoma | completed | Phase 1 | 43 | New Mexico Cancer Research AllianceOTHER | 1 | Jun 18, 2015 | clinicaltrials |
| NCT01544322 | Dose Escalation Study of the Safety and Pharmacokinetics of ME-344 Single Agent for Refractory Solid Tumors(ME-344-001) | completed | Phase 1 | 24 | MEI Pharma, Inc.INDUSTRY | 1 | Jun 18, 2015 | clinicaltrials |
| NCT00099346 | MK0457 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Colorectal Cancer and Other Advanced Solid Tumors (0457-001) | terminated | Phase 1 | — | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jun 17, 2015 | clinicaltrials |
| NCT01271972 | Study of Nesvacumab (REGN910/ SAR307746) | completed | Phase 1 | 53 | Regeneron PharmaceuticalsINDUSTRY | 2 | Jun 16, 2015 | clinicaltrials |
| NCT01490047 | Single Dose of Intravenous rhTNF-α and Liposomal Doxorubicin in Patients With Advanced Solid Tumors or Lymphomas | withdrawn | Phase 1 | 0 | Ludwig Institute for Cancer ResearchOTHER | 1 | Jun 16, 2015 | clinicaltrials |
| NCT00096941 | A Study to Evaluate Subjects Treated With rhuMab 2C4 (Pertuzumab) in a Previous Genentech Phase II Cancer Study | completed | Phase 2 | 3 | Genentech, Inc.INDUSTRY | 0 | Jun 11, 2015 | clinicaltrials |
| NCT01017731 | Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes | completed | Phase 2 | 68 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 10, 2015 | clinicaltrials |
| NCT02120118 | Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) in Treatment Failure Solid Tumors | withdrawn | Phase 2 | 0 | Shin Kong Wu Ho-Su Memorial HospitalOTHER | 1 | Jun 9, 2015 | clinicaltrials |
| NCT00005078 | Tirapazamine, Carboplatin, and Paclitaxel in Treating Patients With Advanced Malignant Solid Tumors | completed | Phase 1 | 44 | City of Hope Medical CenterOTHER | 1 | Jun 8, 2015 | clinicaltrials |
| NCT00005839 | Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jun 8, 2015 | clinicaltrials |
| NCT00550901 | Dexrazoxane and Cisplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 25 | City of Hope Medical CenterOTHER | 0 | Jun 8, 2015 | clinicaltrials |
| NCT01602289 | A Study of LY2875358 in Japanese Participants With Advanced Cancer | completed | Phase 1 | 17 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 8, 2015 | clinicaltrials |
| NCT01846429 | Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain | terminated | Phase 1 | 9 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jun 4, 2015 | clinicaltrials |
| NCT02199548 | The Good Patient Study | completed | — | 43 | St. Jude Children's Research HospitalOTHER | 1 | Jun 4, 2015 | clinicaltrials |
| NCT00770263 | Erlotinib and Temsirolimus for Solid Tumors | completed | Phase 1 | 46 | Washington University School of MedicineOTHER | 1 | Jun 3, 2015 | clinicaltrials |
| NCT00770419 | Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers | withdrawn | — | 0 | Rutgers, The State University of New JerseyOTHER | 0 | May 29, 2015 | clinicaltrials |
| NCT00899808 | Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer | withdrawn | — | 0 | Rutgers, The State University of New JerseyOTHER | 1 | May 29, 2015 | clinicaltrials |
| NCT00388427 | Safety Study Of Cetuximab Plus Dasatinib (BMS-354825) in Treating Advanced Solid Malignancies | completed | Phase 1 | 31 | University of PittsburghOTHER | 1 | May 28, 2015 | clinicaltrials |
| NCT00423865 | Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 25, 2015 | clinicaltrials |
| NCT01281150 | Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 22 | National Cancer Institute (NCI)NIH | 1 | May 25, 2015 | clinicaltrials |
| NCT00535119 | Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer | completed | Phase 1 | 107 | National Cancer Institute (NCI)NIH | 1 | May 22, 2015 | clinicaltrials |
| NCT01764087 | A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors | unknown | Phase 1 / Phase 2 | 60 | Hanmi Pharmaceutical Company LimitedINDUSTRY | 1 | May 18, 2015 | clinicaltrials |
| NCT02446431 | Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence(Metronomic) | recruiting | Early Phase 1 | 20 | Miller Children's & Women's Hospital Long BeachOTHER | 1 | May 18, 2015 | clinicaltrials |
| NCT00951158 | A Molecular Pharmacodynamic Dose-titration Trial of Conjugated Linoleic Acid (CLA; Clarinol®) in Patients With Advanced Solid Tumors | terminated | Phase 1 | 4 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | May 12, 2015 | clinicaltrials |
| NCT00521144 | Obatoclax Mesylate and Topotecan Hydrochloride in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer or Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 22 | National Cancer Institute (NCI)NIH | 1 | May 5, 2015 | clinicaltrials |
| NCT00070252 | Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer | completed | Phase 1 / Phase 2 | 53 | National Cancer Institute (NCI)NIH | 1 | May 4, 2015 | clinicaltrials |
| NCT00245076 | Smokefree.Gov Website in Helping United States Federal Employees Quit Smoking | completed | N/A | — | National Cancer Institute (NCI)NIH | 1 | May 1, 2015 | clinicaltrials |
| NCT01343498 | Study of PI3 Kinase/mTOR Inhibitor BEZ235 Twice Daily for Advanced Solid Tumors | completed | Phase 1 | 33 | SCRI Development Innovations, LLCOTHER | 1 | May 1, 2015 | clinicaltrials |
| NCT00018967 | Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate | completed | N/A | 10 | National Cancer Institute (NCI)NIH | 4 | Apr 30, 2015 | clinicaltrials |
| NCT00020488 | Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00030095 | 2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00042861 | UCN-01, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00045500 | UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00072111 | Anakinra in Treating Patients With Metastatic Cancer Expressing the Interleukin-1 Gene | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00003993 | Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma | completed | Phase 1 | 24 | National Institute on Aging (NIA)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00019344 | Flavopiridol in Treating Patients With Refractory Cancer | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00019357 | Interleukin-2 Plus Activated White Blood Cells in Treating Patients With Cancer That Has Not Responded to Chemotherapy or Radiation Therapy | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00019656 | Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00020150 | Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00040729 | Genetic Study of Patients Previously Treated With Flavopiridol on Clinical Trial NCI-97-C-0171C | completed | — | — | National Cancer Institute (NCI)NIH | 1 | Apr 28, 2015 | clinicaltrials |
Data updated 24 days agoSource updated Jul 14, 2015source: clinicaltrials